BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28704499)

  • 21. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.
    Li J; Yu T; Cao J; Liu L; Liu Y; Kong HW; Zhu MX; Lin HC; Chu DD; Yao M; Yan MX
    Cell Physiol Biochem; 2015; 37(5):1847-56. PubMed ID: 26584284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
    Lei W; Kang W; Nan Y; Lei Z; Zhongdong L; Demin L; Lei S; Hairong H
    Oncol Res; 2018 Aug; 26(7):1015-1022. PubMed ID: 29321091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.
    Luo W; Huang B; Li Z; Li H; Sun L; Zhang Q; Qiu X; Wang E
    PLoS One; 2013; 8(5):e64759. PubMed ID: 23734217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p.
    Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C
    BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
    Fu Y; Li Y; Wang X; Li F; Lu Y
    Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
    He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
    BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
    Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
    Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
    Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
    Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression pattern of miR-451 and its target
    Mamoori A; Gopalan V; Lu CT; Chua TC; Morris DL; Smith RA; Lam AK
    J Clin Pathol; 2017 Apr; 70(4):308-312. PubMed ID: 27612504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
    Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
    Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
    Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.